CLDN16 and nephrocalcinosis: Mice lacking Cldn16 develop hypercalciuria and hypomagnesemia, which is similar to the phenotype of patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) that carry pathogenic variants in CLDN1650.